Ann: Positive EMA Meeting For Phase 3 Disc Repair Program, page-18

Agreed.

MSB is not far away from its valuation that occured after it signed its deal with Cephalon. Meaning the stock is almost back to square one.

Now that shouldn't occur with a stock if it genuinely has met major milestones along the way. I understand the constant refrain of manipulation because at these price levels it is basically like MSB has done nothing since its Cephalon deal.

Which I suppose from a certain point of view is true. Since the cephalon deal they have progressed true but nothing of SUBSTANCE has occured since the cephalon deal.